Zoetis Inc. (ZTS) Social Stream
ZOETIS INC (ZTS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ZOETIS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-05 | 12 | $258 | $184 | $235.875 | $196.71 | 19.91% |
| 2021-11-18 | 13 | $264 | $184 | $239 | $196.71 | 21.5% |
| 2021-12-10 | 13 | $264 | $184 | $242.555 | $196.71 | 23.31% |
| 2022-01-03 | 13 | $264 | $232 | $247.888 | $196.71 | 26.02% |
| 2022-02-16 | 13 | $275 | $232 | $250.666 | $196.71 | 27.43% |
| 2022-04-26 | 13 | $275 | $230 | $249.666 | $196.71 | 26.92% |
| 2022-05-02 | 13 | $275 | $230 | $247.555 | $196.71 | 25.85% |
| 2022-05-06 | 13 | $275 | $232 | $249.75 | $196.71 | 26.96% |
| 2022-05-12 | 13 | $275 | $205 | $244.777 | $196.71 | 24.44% |
| 2022-07-21 | 11 | $264 | $202 | $230.8 | $196.71 | 17.33% |
| 2022-08-01 | 12 | $264 | $202 | $230.8 | $196.71 | 17.33% |
| 2022-08-05 | 12 | $264 | $202 | $232.7 | $196.71 | 18.3% |
| 2022-08-07 | 12 | $264 | $202 | $229.8 | $196.71 | 16.82% |
| 2022-10-12 | 11 | $264 | $202 | $229.8 | $196.71 | 16.82% |
| 2022-10-26 | 11 | $264 | $202 | $227.3 | $196.71 | 15.55% |
| 2022-11-03 | 11 | $264 | $180 | $225.1 | $196.71 | 14.43% |
| 2022-11-13 | 11 | $264 | $170 | $212.333 | $196.71 | 7.94% |
| 2022-11-15 | 11 | $250 | $170 | $210.555 | $196.71 | 7.04% |
| 2022-12-20 | 11 | $250 | $170 | $207.875 | $196.71 | 5.68% |
| 2023-01-30 | 11 | $250 | $170 | $210.375 | $196.71 | 6.95% |
| 2023-02-15 | 11 | $250 | $180 | $214.125 | $196.71 | 8.85% |
| 2023-04-12 | 12 | $260 | $180 | $219.222 | $196.71 | 11.44% |
| 2023-04-25 | 12 | $260 | $180 | $218.111 | $196.71 | 10.88% |
| 2023-05-04 | 11 | $260 | $180 | $218.111 | $196.71 | 10.88% |
| 2023-05-15 | 11 | $260 | $180 | $217 | $196.71 | 10.31% |
| 2023-07-20 | 12 | $260 | $180 | $217.8 | $196.71 | 10.72% |
| 2023-08-08 | 12 | $260 | $180 | $216.8 | $196.71 | 10.21% |
| 2023-08-10 | 12 | $260 | $195 | $223.1 | $196.71 | 13.42% |
| 2023-08-14 | 12 | $260 | $195 | $224.1 | $196.71 | 13.92% |
| 2023-08-28 | 12 | $260 | $195 | $225.1 | $196.71 | 14.43% |
| 2023-10-02 | 12 | $260 | $195 | $225.545 | $196.71 | 14.66% |
| 2023-10-19 | 12 | $260 | $195 | $224.636 | $196.71 | 14.2% |
| 2023-10-27 | 12 | $260 | $195 | $224.181 | $196.71 | 13.97% |
| 2023-11-02 | 12 | $260 | $195 | $223.272 | $196.71 | 13.5% |
| 2023-11-05 | 12 | $260 | $195 | $223.727 | $196.71 | 13.73% |
| 2023-11-09 | 12 | $255 | $195 | $223.272 | $196.71 | 13.5% |
| 2023-12-07 | 13 | $255 | $195 | $222.09 | $196.71 | 12.9% |
| 2023-12-19 | 13 | $255 | $195 | $222.75 | $196.71 | 13.24% |
The Trend in the Analyst Price Target
ZTS's average price target has moved up $82.32 over the prior 43 months.
Over the past 47 weeks, ZTS's average upside potential has been 26.13%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-27 | 11 | 250 | 170 | 210.375 | 165.18 | 27.36% |
| 2023-02-15 | 12 | 250 | 180 | 212.250 | 175.02 | 21.27% |
| 2023-02-15 | 11 | 250 | 180 | 212.250 | 175.02 | 21.27% |
| 2023-07-23 | 12 | 260 | 180 | 218.800 | 183.51 | 19.23% |
| 2023-08-13 | 12 | 260 | 195 | 224.100 | 190.83 | 17.43% |
ZTS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.04 | 12 | 1 | 0 | 0 | 0 | 13 |
The Trend in the Broker Recommendations
ZTS's average broker recommendation rating improved by 0.01 over the prior 17 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how ZOETIS INC fares relative to all US stocks, note that its average analyst price target is greater than 4271.81% of that group.
- In the context of Pharmaceutical Products stocks, ZOETIS INC's variance in analysts' estimates is lower than -652.54% of them.
- In terms of how ZOETIS INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1015.76% of that group.
- ZOETIS INC's number of analysts covering the stock is higher than 3659.95% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ZOETIS INC are ALKS, JAZZ, and ALNY.
View All Top Stocks by Price Target
Is ZTS a Buy, Hold or Sell? See the POWR Ratings now!